Increased Plasma Levels of Triglyceride-Enriched Lipoproteins Associate with Systemic Inflammation, Lipopolysaccharides, and Gut Dysbiosis in Common Variable Immunodeficiency

Purpose Triglycerides (TG) and their major transport lipoprotein in the circulation (VLDL) appear to be related to inflammation. Patients with common variable immunodeficiency (CVID) have inflammatory complications associated with gut microbial dysbiosis. We hypothesized that CVID patients have dist...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of clinical immunology 2023-08, Vol.43 (6), p.1229-1240
Hauptverfasser: Macpherson, Magnhild E., Skarpengland, Tonje, Hov, Johannes R., Ranheim, Trine, Vestad, Beate, Dahl, Tuva B., Fraz, Mai S. A., Michelsen, Annika E., Holven, Kirsten B., Fevang, Børre, Berge, Rolf K., Aukrust, Pål, Halvorsen, Bente, Jørgensen, Silje F.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Purpose Triglycerides (TG) and their major transport lipoprotein in the circulation (VLDL) appear to be related to inflammation. Patients with common variable immunodeficiency (CVID) have inflammatory complications associated with gut microbial dysbiosis. We hypothesized that CVID patients have disturbed TG/VLDL profiles associated with these clinical characteristics. Methods We measured plasma concentrations of TGs, inflammatory markers, and lipopolysaccharide (LPS) in 95 CVID patients and 28 healthy controls. Additionally, in 40 CVID patients, we explored plasma lipoprotein profiling, fatty acid, gut microbial dysbiosis, and diet. Results TG levels were increased in CVID patients as compared to healthy controls (1.36 ± 0.53 mmol/l versus 1.08 ± 0.56 [mean, SD], respectively, P  = 0.008), particularly in the clinical subgroup “ Complications ,” characterized by autoimmunity and organ-specific inflammation, compared to “ Infection only ” (1.41 mmol/l, 0.71[median, IQR] versus [1.02 mmol/l, 0.50], P  = 0.021). Lipoprotein profile analyses showed increased levels of all sizes of VLDL particles in CVID patients compared to controls. TG levels correlated positively with CRP (rho = 0.256, P  = 0.015), IL-6 (rho = 0.237, P  = 0.021), IL-12 (rho = 0.265, P  = 0.009), LPS ( r  = 0.654, P  = 6.59 × 10 −13 ), CVID-specific gut dysbiosis index ( r  = 0.315, P  = 0.048), and inversely with a favorable fatty acid profile (docosahexaenoic acid [rho =  − 0.369, P  = 0.021] and linoleic acid [rho =  − 0.375, P  = 0.019]). TGs and VLDL lipids did not appear to be associated with diet and there were no differences in body mass index (BMI) between CVID patients and controls. Conclusion We found increased plasma levels of TGs and all sizes of VLDL particles, which were associated with systemic inflammation, LPS, and gut dysbiosis in CVID, but not diet or BMI.
ISSN:0271-9142
1573-2592
DOI:10.1007/s10875-023-01475-x